How to Diagnose Low HCP Engagement Without Blaming Creative First
An ordered diagnostic for low HCP campaign engagement that checks delivery, audience, context, and frequency before concluding the creative is the problem.
The short answer
When HCP engagement is low, the first request is usually new creative. Creative is sometimes the problem. But creative changes in pharma take weeks of review, and they are expensive. Before asking for them, rule out the causes that are faster to find and fix. Most low-engagement problems start upstream of the creative.
Diagnose in this order
The order matters because each step can hide the next. If the ads are not reaching the right prescribers, no creative change will help.
1. Delivery: are the ads being served and seen?
- Is spend pacing to plan?
- What share of impressions is viewable and free of invalid traffic?
- Are impressions concentrated on a small number of sites or apps?
Low viewability or high invalid traffic can make engagement look weak when the real problem is supply. The MRC standards define the delivery metrics to check.
2. Audience: are they reaching the target list?
- What is reach against the intended universe, not just the matchable one?
- Is delivery concentrated in low-priority segments?
- Has the list been audited for stale or inactive NPIs?
3. Context: where are ads appearing?
- Are ads running in professional environments or in general content where prescribers are unlikely to engage?
- Is mobile in-app inventory dominating, with short sessions and accidental clicks?
4. Frequency: too little or too much?
- Average frequency can hide extremes. Look at the distribution.
- A few prescribers seeing 40 impressions and most seeing one produces low engagement across the board.
5. Landing experience: does the click lead somewhere useful?
- Does the landing page load quickly on mobile?
- Does it match the ad's promise?
- Is the HCP gate adding friction?
6. Then creative
If delivery, audience, context, frequency, and landing all look reasonable, creative becomes the most likely cause. Now the change request is well supported.
A quick diagnostic table
| Symptom | Most likely upstream cause |
|---|---|
| Low engagement across all creatives and partners | Audience or landing experience |
| Low engagement at one partner only | Supply quality or audience match at that partner |
| Engagement falling over time | Frequency fatigue or creative wear-out |
| High clicks, low site engagement | Invalid traffic or accidental mobile clicks |
| Good engagement in one specialty, poor in another | Message relevance or specialty mapping |
Compare against a reasonable baseline
"Low" needs a reference. Compare engagement against the brand's own prior campaigns in similar formats, not against benchmarks from other categories. Where you have no baseline, set a provisional one after the first two weeks and track change from there.
Practical takeaway
Before any creative change request, complete a one-page diagnostic covering delivery, audience, context, frequency, and landing experience. Attach it to the request. It either prevents an unnecessary creative change or makes the case for one much stronger.
Sources
- Media Rating Council, Standards and Guidelines
- FDA, Presenting Risk Information in Prescription Drug and Medical Device Promotion
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.